Elad Anter, MD, is Director of Electrophysiology Research and an Assistant Professor of Medicine at Harvard Medical School. His main clinical and research focus is the study of arrhythmia mechanisms and the development of novel ablation technologies to improve patient outcomes.
Aarti H. Asnani, MD, is an attending physician in the Cardio-Oncology Program and a researcher in this field. She joined BIDMC in 2017. Her goal is to define the molecular mechanisms responsible for chemotherapy-induced heart toxicity, a major contributor to morbidity and mortality in the growing population of cancer survivors. Her research interests include the molecular pathways contributing to heart failure induced by a commonly used chemotherapy, doxorubicin.
Mark Benson, MD, is Director of Preventive Cardiology at BIDMC and an Instructor of Medicine at Harvard Medical School. His main clinical and research focus is on the application of emerging metabolomics, proteomics, and clinical phenotypic methods to identify new targets for preventive atherosclerotic cardiovascular disease therapy. He works with a diverse group of collaborators and fellows to develop new ways to further study these methods in both laboratory and clinical settings.
Alfred E. Buxton, MD, is Professor of Medicine at Harvard Medical School and Director of the ECG Laboratory and the Clinical Cardiac Electrophysiology Fellowship Program at BIDMC. Dr. Buxton was Principal Investigator of the NIH-funded Multicenter Study of Non-Sustained Ventricular Tachycardia (MUSTT). His current research is focused on methods to predict risk of sudden cardiac death, the appropriate role of implantable defibrillators for prevention of sudden cardiac death and mechanisms of ventricular tachycardia.
Brett Carroll, MD, is Director of Vascular Medicine at BIDMC and Instructor in Medicine at Harvard Medical School. He staffs the inpatient vascular medicine consult service and directs the Massive and Submassive Clot On-Call Team, BIDMC's PE response team. His outpatient clinic focuses on aortic disease, peripheral vascular disease, venous thromboembolism, and lymphatic medicine, in addition to general cardiology. He also interprets vascular laboratory studies. His research interests include pulmonary embolism, lymphedema and management of aortic disease.
James D. Chang, MD, is Associate Professor of Medicine at Harvard Medical School and a member of the CardioVascular Institute's Advanced Heart Failure Center program. He is involved in research activities pertaining to early detection and prevention of cancer therapeutics-associated cardiotoxicity and to the role of implantable hemodynamic monitoring devices in the management of advanced heart failure. In addition to his work in advanced heart failure, he is an active member of the echocardiography laboratory.
Donald Cutlip, MD, is an interventional cardiologist and Vice Chair for Network Management and Development in the Department of Medicine. He is Professor of Medicine at Harvard Medical School and a Senior Investigator at the Baim Institute for Clinical Research. His research interests include the study of clinical outcomes after percutaneous coronary intervention with special interest in patients with diabetes and stent thrombosis.
Loryn S. Feinberg, MD, is the director of the Women’s Cardiovascular Health Program at Beth Israel Deaconess Medical Center. She joined the cardiology staff at Beth Israel Medical Center in 2006. Dr. Feinberg’s clinical areas of interest include women and heart disease, pregnancy and cardiovascular disease and cardio-oncology.
Airley E. Fish, MD, MPH, is an Instructor of Medicine at Harvard Medical School and joined the Division of Cardiovascular Medicine in 2010. Her clinical interests include coronary artery disease, valvular heart disease, preventive cardiology and cardiovascular diseases in women.
Michael C. Gavin, MD, MPH, is Director of the CVI's Cardiac Direct Access Unit, Director of Inpatient Cardiology at BIDMC and an Instructor of Medicine at Harvard Medical School. Dr. Gavin's clinical practice focuses on valvular heart disease, coronary artery disease and preventive cardiology.
Eli Gelfand MD, is an Assistant Professor of Medicine at Harvard Medical School and Section Chief of General Cardiology at BIDMC where he is responsible for cardiovascular outpatient operations. He is also active in developing the clinical applications of new and rapidly evolving diagnostic imaging modalities, such as three-dimensional (3D) and intracardiac echocardiography (ICE) and cardiovascular magnetic resonance (CMR) imaging with particular focus on imaging support of minimally-invasive therapies for valvular and congenital cardiac disease.
Ernest Gervino, ScD, is an Associate Professor of Medicine at Harvard Medical School and the Director of the Clinical Physiology Laboratory at BIDMC. He also serves as the Director of Exercise Testing Core Lab for both national and international research trials at the Baim Institute. His research interests include the effects of exercise training on management of patients, diet and behavior modification on the reduction of risk for a second cardiac event.
C. Michael Gibson, MD, is a Professor of Medicine at Harvard Medical School and an interventional cardiologist, cardiovascular researcher and educator who has led his own Academic Research Organization (PERFUSE) for over 20 years. His work has been presented in over 1,000 manuscripts, abstracts, trial summaries, textbooks and textbook chapters. He is founder and Chairman of the Board of the non-profit WikiDoc foundation, the world’s largest open source textbook of medicine.
Ary Goldberger, MD, , Professor of Medicine at Harvard Medical School, is Director of the Margret and H.A. Rey Institute for Nonlinear Dynamics in Physiology and Medicine and Program Director of the NIH/NCRR Research Resource for Complex Signals (www.physionet.org.). Dr. Goldberger and his colleagues have pioneered the application of fractals to physiology and methods to quantify the breakdown of fractal scaling as they pertain to aging and disease.
E. Wilson Grandin, MD, specializes in advanced heart failure. He is site director of the joint BIDMC-Tufts Medical Center Advanced Fellowship in Heart Failure and Cardiac Transplantation.
Charles Haffajee, MD, is an Associate Professor of Medicine at Harvard Medical School and Director of Device Trials and Cardiac Electrophysiology Network Development. His primary interests are in pacing, defibrillation, congestive heart failure and atrial fibrillation.
Thomas Hauser, MD, is an Assistant Professor of Medicine at Harvard Medical School and Director of Nuclear Cardiology Medicine in the CardioVascular Institute. His primary research interest is in the clinical application of advanced methods of cardiovascular imaging with particular focus on nuclear cardiology and cardiac MR.
Kalon Ho, MD, is an Assistant Professor of Medicine and the Director of Quality Assurance for BIDMC’s Division of Cardiovascular Medicine. He leads BIDMC’s efforts to monitor the outcomes and improve quality of cardiovascular care. His research interests include methodological issues in the design, management and analyses of clinical trials; cost-effectiveness of cardiac interventions; and assessment of outcomes of cardiovascular procedures, including use of large-scale, multicenter databases.
Peter M. Kang, MD, is an Associate Professor of Medicine at Harvard Medical School and Director of the Cardiac Physiology Core in BIDMC's Cardiovascular Research Program. His laboratory is developing novel nanoparticle-based systems that are activated by hydrogen peroxide, for use in cardiovascular therapeutics and bio-imaging applications, and is currently investigating the molecular mechanism of cardiac dysfunction associated with vitamin D deficiency and examining the potential role of vitamin D therapy in the treatment of heart failure.
Joseph P. Kannam, MD, is an Assistant Professor of Medicine at Harvard Medical School and director of the Cardiovascular Fellowship Program at Beth Israel Deaconess Medical Center. He is Chief of the Division of Cardiology at Beth Israel Deaconess Hospital-Needham (BID-Needham) and oversees the hospital’s comprehensive community-based cardiology program. He makes annual trips to Haiti with the organization Hearts Around the World to train local physicians in cardiovascular care.
Daniel Kramer, MD, is an Assistant Professor of Medicine at Harvard Medical School and Director of the Pacemaker and ICD Service in the Division of Electrophysiology.. Dr. Kramer’s research focuses on understanding and improving outcomes of patients with cardiac devices as well as policy analyses of medical device regulation.
Roger J. Laham, MD, is an Associate Professor of Medicine at Harvard Medical School and Co-Director of the Peripheral Vascular Disease Program. Dr. Laham is investigating novel angiogenesis and myogenesis strategies including stem cell and myotissue transplantations and novel imaging modalities including Multidetector CT (320) for coronary artery disease detection and PET/CT for vulnerable plaque imaging. In addition, he is developing and studying several cardiovascular devices including percutaneous valves, left atrial exclusion for atrial fibrillation, and myocardial restraint for congestive heart failure.
Warren J. Manning, MD, is Professor of Medicine and Professor of Radiology at Harvard Medical School and the Section Chief of Noninvasive Cardiac Imaging and Testing in the CVI, where he also serves as Co-director of the Cardiac MR Center and Director of the Echocardiography Laboratory. A former president of the Society for Cardiovascular Magnetic Resonance, his ongoing research interests include cardiovascular applications of magnetic resonance (coronary MRI, valvular heart disease, subclinical atherosclerosis, atrial fibrosis in atrial fibrillation and pericarditis), utilization of echocardiography for prognosis in valvular heart disease and appropriateness of echocardiographic referrals.
Murray A. Mittleman, MD, DrPH, is an Associate Professor of Medicine at Harvard Medical School and serves as Chair of the Master of Public Health program at the Harvard School of Public Health.and oversees cardiovascular epidemiology in the division of Preventive Cardiology in the CVI. He is a national leader in applied research is in the areas of environmental and behavioral determinants of the onset of acute cardiovascular events, including myocardial infarction, arrhythmias, stroke and congestive heart failure decompensation.
Reza Nezafat, PhD, is an Associate Professor of Medicine at Harvard Medical School and serves as the Scientific Director of the Cardiac MR Center. Dr. Nezafat’s research focuses on the development and applications of new non-invasive methods in magnetic resonance imaging to guide therapy in cardiovascular disease.
Eric Osborn, MD, PhD, is an Instructor in Medicine at Harvard Medical School and the Director of the Interventional Cardiology Fellowship Program. His clinical interests include complex coronary percutaneous intervention and intravascular imaging. His research involves intravascular molecular imaging and optical coherence tomography to define coronary plaque biology and mechanisms of coronary stent healing in vivo.
Panos Papageorgiou, MD, is an Assistant Professor of Medicine at Harvard Medical School. He is a staff electrophysiologist of the Harvard-Thorndike Institute of Electrophysiology. Dr. Papageorgiou’s basic research has included the exploration of the role of the myocardial chloride/bicarbonate exchanger in atrial myocytes, and complex heart rhythm analysis in transgenic mice. His clinical research has focused on atrial anisotropy and atrial pacing for atrial fibrillation prevention.
Duane S. Pinto, MD, is Associate Professor of Medicine, Director of the Cardiac Catheterization Laboratory and Chief of the Interventional Cardiology section. He performs complex coronary and peripheral vascular intervention and and his research interests include cost effectiveness evaluation of anticoagulation strategies for acute coronary syndromes as well as the development of approaches to improve outcomes after myocardial infarction.
Pablo Quintero Pinzon, MD, is an Instructor of Medicine at Harvard Medical School. Originally from Colombia, he is also part of the Cardiovascular Latino Clinic which delivers culturally sensitive cardiovascular care for Spanish-speaking patients. Dr. Quintero Pinzon sees patients at BIDMC and at BIDMC-Chelsea. His research interest include heart failure/ventricular remodeling.
Jeffrey Popma, MD, is a Professor of Medicine at Harvard Medical School and Director of Interventional Clinical Cardiology and of the BIDMC Angiographic Core Laboratory for numerous multicenter device studies. Over the past 15 years, he has led national clinical trials investigating a broad array of new technologies, including bare metal stents, drug eluting stents, distal protection devices, total occlusion devices, carotid and peripheral revascularization procedures and transcatheter aortic valve and mitral valve therapies.
Carl Rasmussen is a staff cardiologist at BIDMC and an Instructor of Medicine at Harvard Medical School. His clinical expertise is in the diagnosis and management of rhythm disturbances, utilizing both invasive and noninvasive methods.
Anne Riley, MD, is an Instructor of Medicine at Harvard Medical School and joined the Cardiovascular Division at BIDMC and BID-Needham in 2011. She is a clinical cardiologist who sees general cardiology patients and performs non-invasive cardiac testing at BID-Needham. She attends on the inpatient cardiology service and the cardiology consult service at BIDMC.
Marwa Sabe, MD, is Associate Director of Advanced Heart Failure and Director of the Left Ventricular Assist Device (LVAD) program. She works with patients with temporary and permanent mechanical support devices and heart transplantations at BIDMC and she spends part of each year working at Tufts Medical Center with advanced heart failure patients who have had placement of LVADs and transplants.
Jeffrey E. Saffitz, MD, PhD, unctions in cardiac myocytes. He has characterized the roles of the individual cardiac connexins in impulse propagation and defined mechanisms by which remodeling of gap junctions in the diseased heart contributes to the pathogenesis of sudden death. His current work is focused on the role of gap junction remodeling in sudden death in arrhythmogenic right ventricular cardiomyopathy.
Samuel Shubrooks, MD, is Associate Professor of Medicine at Harvard Medical School and a member of the interventional cardiology section. Dr. Shubrooks' clinical and research interests include interventional cardiology and aortic and mitral valvuloplasty.
Alexei Shvilkin is a Clinical Assistant Professor of Medicine at Harvard Medical School He completed residencies at Jacobi Medical Center in Medicine and at BIDMC in in Cardiology and a fellowship at BIDMC in Cardiac Electrophysiology. Dr. Shvilkin is an electrophysiologist at both BIDMC and South Shore Hospital.
Jordan B. Strom, MD, is Instructor of Medicine at Harvard Medical School and a non-invasive cardiologist, specializing in echocardiography and cardiovascular magnetic resonance. He is an investigator at the Smith Center for Outcomes Research in Cardiology, where he evaluates the impact of public policies and cardiovascular care structures on health outcomes, using large administrative, registry and clinical trial data to refine prediction of cardiovascular disease states and to evaluate comparative effectiveness of cardiovascular therapies.
Hector Tamez, MD, MPH, is an Instructor in Medicine at Harvard Medical School and an interventional cardiologist specializing in complex coronary interventions. He is an investigator in the Smith Center for Outcomes Research in Cardiology. His current research interests focus on outcomes after complex percutaneous coronary interventions (chronic total occlusions and in-stent restenosis) and on bleeding and thrombotic outcomes after percutaneous coronary intervention.
Connie Tsao, MD, is an Instructor in Medicine at Harvard Medical School. She is a non-invasive cardiologist specializing in clinical cardiovascular imaging (echocardiography, cardiovascular magnetic resonance) and an investigator at the Framingham Heart Study. Her research interests are in noninvasive assessment of cardiovascular structure and function, and the epidemiology of subclinical CVD, cardiac remodeling, vascular stiffness and heart failure.
Richard Verrier, PhD, s an Associate Professor of Medicine at Harvard Medical School and Director of the Integrative Cardiac Electrophysiology Laboratory. His research focuses on neural control of heart rhythm with particular reference to the problem of sudden cardiac death. He and his colleagues have demonstrated that T-wave alternans (TWA) magnitude provides a noninvasive index of vulnerability to lethal cardiac arrhythmias and have generated FDA-cleared means to perform TWA testing during routine exercise and ambulatory ECG monitoring.
Jonathan W. Waks, MD, is an Instructor in Medicine at Harvard Medical School. Dr. Waks' main research interests involve use of novel electrocardiographic and vectorcadiographic methods of assessing risk for ventricular arrhythmias and sudden cardiac death. He sees patients in the electrophysiology clinic on Shapiro 7, implants pacemakers and defibrillators, and performs ablations as well as electrophysiology studies.
Francine K. Welty, MD, is an Associate Professor of Medicine at Harvard Medical School and Principal Investigator and Director of the NHLBI Specialized Center of Clinically Oriented Research in Vascular Injury, Repair and Remodeling. Dr. Welty is principal investigator of the Kuwait Healthy Life Study which examined 8,139 Kuwaiti children at baseline in 2012 with a 2-year follow-up in 2014. With a clinical focus on lipid disorders, preventive cardiology and heart disease in women, she was recently appointed Chair of the Clinical Lipid Committee of the National American Heart Association.
Meghan York, MD, is an Instructor of Medicine at Harvard Medical School and joined the Cardiovascular Institute in 2011. She attends on the general cardiology inpatient and consult services at BIDMC and maintains an active general cardiology practice at Beth Israel Deaconess – Needham Hospital.
CVI Affiliated Physicians at Harvard Vanguard Medical Associates
Interventional Cardiology/Catheterization Laboratory
Dr. Mandeep S. Dhadly is the Chief of the Cardiology Department at Harvard Vanguard Medical Associates. Specific clinical interests include both diagnostic and interventional cardiac and peripheral vascular procedures.
Dr. Mobeen A. Sheikh is an interventional cardiologist and vascular medicine specialist. His clinical interests include coronary and peripheral vascular procedures and his chief research interest is in peripheral arterial disease.
Dr. Kapil (Bobby) Kumar is a Clinical Instructor in Medicine at Harvard Medical School and a member of the BIDMC Electrophysiology section. He directs the Electrophysiology and Cardiac Device Service at Harvard Vanguard Medical Associates. Dr. Kumar’s research interests include non-invasive sudden cardiac death risk assessment and the evaluation of novel antiarrhythmic drugs
Dr. Jane S. Bae is a Clinical Instructor in Medicine at Harvard Medical School. She focuses on clinical and preventative cardiology, has an interest in vascular imaging and specializes in non-invasive cardiovascular imaging including echocardiography and nuclear imaging.
Dr. Patricia A. Come is an Associate Professor of Medicine at Harvard Medical School for over 25 years. She focuses on clinical cardiology and preventative cardiology and is an echocardiographer.
Dr. Andre Dejam is a non-invasive cardiologist that is interested in heart failure. He directs the heart failure program at Harvard Vanguard. His interests are understanding diuretic resistance and establishing systems approaches for CHF patients to avoid hospital admissions.
Dr. Geoffrey S. Hirsowitz is a Clinical Instructor in Medicine at Harvard Medical School. He focuses on clinical cardiology and preventative cardiology.
Dr. Marshall S. Katz is a Clinical Instructor in Medicine at Harvard Medical School. Dr. Katz is the medical director for the Echo lab at Harvard Vanguard Medical Associates. He specializes in non-invasive cardiology, including nuclear, stress testing, echocardiographic imaging and pacemaker follow-up.
Dr. Steven Lampert is a Clinical Instructor in Medicine at Harvard Medical School. Dr. Lampert was the Chief of the Cardiology Department at Harvard Vanguard Medical Associates from 1996-2010. Dr. Lampert focuses on clinical cardiology and preventative cardiology and is particularly interested in congestive heart failure, arrhythmias, pacemakers and ICDs and lipid management.
Dr. Meredith J. Mulhearn focuses on clinical cardiology and preventative cardiology and specializes in non-invasive cardiology including nuclear imaging and echocardiographic imaging. She has a special interest in cardiac rehabilitation.
Dr. Sanjay Shrivastava is a Clinical Instructor in Medicine at Harvard Medical School. Dr. Shrivastava focuses on clinical cardiology and preventative cardiology and specializes in non-invasive cardiovascular imaging including echocardiography, nuclear cardiology and stress testing. His clinical interest includes application of novel biomarkers in cardiovascular disease.
Dr. Mark B. Stockman is a Clinical Instructor in Medicine at Harvard Medical School. Dr. Stockman was the Chief of the Cardiology Department at Harvard Vanguard Medical Associates from 1985-1995. He focuses on clinical cardiology, preventative cardiology and pacemaker follow-up.